<DOC>
	<DOC>NCT00688870</DOC>
	<brief_summary>The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC), relative to a 7-valent pneumococcal conjugate vaccine (7vPnC) when given concomitantly with routine vaccines in Taiwan.</brief_summary>
	<brief_title>Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy 2monthold infants (42 to 98 days) Available for the entire study period (14 months) Previous vaccination with pneumococcal, diphtheria, tetanus, pertussis, polio, or Hib vaccines A previous anaphylactic reaction to any vaccine or vaccinerelated component.</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Prevention against pneumococcal disease</keyword>
</DOC>